Trial NCT00727194

View at ClinicalTrials.gov 
Org. Study IDs: C08-001

Last trial update was posted on 2019-09-24

MeSH Interventions

Eculizumab

MeSH Conditions

Muscle Weakness Myasthenia Gravis

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

Small sample size limited ability to detect intercohort differences. Carryover effect from Treatment Period (TP) 1 warrants cautious interpretation of TP 2 data. Study terminated early; 13 patients received eculizumab or placebo in TP2.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID